Mrs Kathleen Kennedy-brill, MA, CCC-SLP | |
806 N Main St, Laconia, NH 03246-2603 | |
(603) 524-9090 | |
(603) 524-1497 |
Full Name | Mrs Kathleen Kennedy-brill |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 806 N Main St, Laconia, New Hampshire |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205504099 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 1495 (New Hampshire) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Kathleen Kennedy-brill, MA, CCC-SLP 806 N Main St, Laconia, NH 03246-2603 Ph: (603) 524-9090 | Mrs Kathleen Kennedy-brill, MA, CCC-SLP 806 N Main St, Laconia, NH 03246-2603 Ph: (603) 524-9090 |
News Archive
Last year, a Wyss Institute team of scientists described the development of a new device to treat sepsis that works by mimicking our spleen. It cleanses pathogens and toxins from blood circulating through a dialysis-like circuit. Now, the Wyss Institute team has developed an improved device that synergizes with conventional antibiotic therapies and that has been streamlined to better position it for near-term translation to the clinic.
CVRx, Inc., a private medical device company, announced today it received CE Mark approval from the National Standards Authority of Ireland of the Barostim neo System for the treatment of heart failure.
Today, Syclo, a market leader in mobile enterprise platforms and applications, announced the availability of a second mobile product resulting from its co-innovation relationship with SAP AG. The new product, SMART Service Manager, was recently selected by a major medical system supplier to hospitals worldwide, to connect their 400 field service technicians to the SAPĀ® Customer Relationship Management (SAP CRM) application.
Illumina, Inc. today announced that its Board of Directors has approved a new stock repurchase program, authorizing the company to repurchase in the aggregate up to $100 million of its outstanding common stock. The $75 million share repurchase program originally announced on August 24, 2009, recently has been completed.
An investigational drug is producing powerful responses in patients resistant to Gleevec, the targeted therapy that helps most people diagnosed with chronic myeloid leukemia (CML), an international research team headed by investigators at The University of Texas M. D. Anderson Cancer Center is reporting.
› Verified 9 days ago
Mr. Shadd Lagrandeur, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-527-2888 | |
Mrs. Sara Willis Carmichael, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 806 N Main St, Laconia, NH 03246 Phone: 603-524-9090 | |
Mrs. Wendy White Lybrand, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 806 N Main St, Laconia, NH 03246 Phone: 603-581-4715 | |
Meredith Bergeron, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 806 N Main St, Laconia, NH 03246 Phone: 603-524-4385 Fax: 603-524-1497 | |
Lindsay M Ladue, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 County Dr, Laconia, NH 03246 Phone: 603-527-5410 | |
Mrs. Heather Ann Sydorwicz, M.S. CCC/SLP, BCBA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 806 N Main St, Laconia, NH 03246 Phone: 603-524-9090 | |
Rileigh O'brien, MA SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 806 N Main St, Laconia, NH 03246 Phone: 603-524-4385 |